(19)
(11) EP 3 941 517 A1

(12)

(43) Date of publication:
26.01.2022 Bulletin 2022/04

(21) Application number: 20711226.9

(22) Date of filing: 20.03.2020
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
A61K 39/21(2006.01)
A61P 31/18(2006.01)
C07K 14/56(2006.01)
C12N 15/86(2006.01)
 A61K 38/21(2006.01)
A61K 39/395(2006.01)
C07K 14/005(2006.01)
C07K 16/24(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/747; A61K 38/21; A61K 39/09; A61K 39/12; A61K 2039/52; A61K 2039/521; A61K 2039/545; A61K 2039/552; A61K 2039/572; A61P 31/14; A61P 31/18; C07K 16/249; C07K 2317/76; C12N 2740/15034; C12N 2740/16034
 
C-Sets:
  1. A61K 38/21, A61K 2300/00;
  2. A61K 35/747, A61K 2300/00;
(86) International application number:
PCT/EP2020/057894
(87) International publication number:
WO 2020/188111 (24.09.2020 Gazette 2020/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.03.2019 US 201962821774 P
21.03.2019 US 201916360876
31.07.2019 EP 19189405

(71) Applicant: 21C BIO
75008 Paris (FR)

(72) Inventor:
  • ZAGURY, Daniel
    75007 Paris (FR)

(74) Representative: Icosa 
83 avenue Denfert-Rochereau
75014 Paris
75014 Paris (FR)

   


(54) VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS